Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Greer

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|April 20, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin’s LymphomaJohn P Greer
Hematology. American Society of Hematology. Education Program|November 25, 2006
Therapy of peripheral T/NK neoplasmsJohn P Greer
Leukemia & Lymphoma|January 9, 2010
Primary bone lymphoma: a set of unique problems in managementNishitha Reddy, John P Greer
Current Hematologic Malignancy Reports|April 29, 2010
Natural killer-cell neoplasmsJohn P Greer, Claudio A Mosse
Journal of the American Academy of Dermatology|December 23, 2006
Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphomaJacob A Sepmeyer, John P Greer, Tatsuki Koyama, et al.
Ocular Oncology and Pathology|August 2, 2019
Blastic Transformation of a Mantle Cell Lymphoma Presenting as an Enlarging Unilateral Orbital MassMatthew A De Niear, John P Greer, Adam Seegmiller, et al.
Journal of the American Academy of Dermatology|April 25, 2006
Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphomaAdriana N Schmidt, Jason B Robbins, John P Greer, et al.
Clinical Lymphoma & Myeloma|March 2, 2006
Non-Hodgkin's lymphoma involving the liver: clinical and therapeutic considerationsJ Stuart Salmon, Mary Ann Thompson, Ronald C Arildsen, et al.
Journal of the American Academy of Dermatology|February 18, 2014
Hemagglutination during photopheresisLisa Mask-Bull, Sunaina B Likhari, John A Zic, et al.
Leukemia & Lymphoma|January 21, 2012
Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapyScott F Huntington, Mahsa S Talbott, John P Greer, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|April 20, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin’s LymphomaJohn P Greer
Hematology. American Society of Hematology. Education Program|November 25, 2006
Therapy of peripheral T/NK neoplasmsJohn P Greer
Leukemia & Lymphoma|January 9, 2010
Primary bone lymphoma: a set of unique problems in managementNishitha Reddy, John P Greer
Current Hematologic Malignancy Reports|April 29, 2010
Natural killer-cell neoplasmsJohn P Greer, Claudio A Mosse
Journal of the American Academy of Dermatology|December 23, 2006
Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphomaJacob A Sepmeyer, John P Greer, Tatsuki Koyama, et al.
Ocular Oncology and Pathology|August 2, 2019
Blastic Transformation of a Mantle Cell Lymphoma Presenting as an Enlarging Unilateral Orbital MassMatthew A De Niear, John P Greer, Adam Seegmiller, et al.
Journal of the American Academy of Dermatology|April 25, 2006
Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphomaAdriana N Schmidt, Jason B Robbins, John P Greer, et al.
Clinical Lymphoma & Myeloma|March 2, 2006
Non-Hodgkin's lymphoma involving the liver: clinical and therapeutic considerationsJ Stuart Salmon, Mary Ann Thompson, Ronald C Arildsen, et al.
Journal of the American Academy of Dermatology|February 18, 2014
Hemagglutination during photopheresisLisa Mask-Bull, Sunaina B Likhari, John A Zic, et al.
Leukemia & Lymphoma|January 21, 2012
Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapyScott F Huntington, Mahsa S Talbott, John P Greer, et al.
Pageof 5